From Amazon retreats to clinical research: The rise of psychedelic therapy
Summary
Psychedelic therapy, which uses hallucinogenic drugs like psilocybin and ayahuasca, is gaining attention as a possible treatment for depression. Clinical trials are underway in the UK, where researchers study if these drugs, taken in controlled settings, can help people manage difficult emotions and improve their mental health.Key Facts
- Claire Torpey traveled to South and Central America to take part in legal psychedelic retreats using psilocybin and ayahuasca to help with anxiety and sadness.
- Psychedelic tourism is growing, but there are risks from unregulated retreats, including reports of deaths.
- Psilocybin and DMT are Class A drugs in the UK, meaning they are considered illegal and without recognized medical use.
- The Newcastle Care Pathway Enhancement (CaPE) Clinic is running clinical trials to see if psilocybin can treat depression.
- Participants take psilocybin capsules and spend several hours in a specially designed room monitored by therapists.
- Researchers believe psychedelics help by temporarily disrupting thought patterns, allowing new perspectives on emotions and memories.
- Experts say these treatments are not a cure but may help some people better understand and manage their depression.
- More studies are needed to confirm how effective and safe psychedelic therapy is for mental health care.
Read the Full Article
This is a fact-based summary from The Actual News. Click below to read the complete story directly from the original source.
